Inhibition of epoxide hydrolase by valproic acid in epileptic patients receiving carbamazepine.

Abstract

The effect of valproic acid (VPA) on the disposition of carbamazepine‐ 10,11‐epoxide (epoxide) was studied in five epileptic patients on chronic carbamazepine (CBZ) therapy. The individual pharmacokinetic parameters influencing epoxide disposition were determined in the presence and absence of VPA. VPA significantly decreased the clearance of unbound epoxide (an in vivo index of epoxide hydrolase activity), but did not appear to affect epoxide formation. VPA also increased the free concentrations of both CBZ and epoxide. 1990 The British Pharmacological Society